125 related articles for article (PubMed ID: 38776461)
1. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [
Kong Y; Cao L; Wang J; Zhuang J; Liu Y; Bi L; Qiu Y; Hou Y; Huang Q; Xie F; Yang Y; Shi K; Rominger A; Guan Y; Jin H; Ni R
ACS Chem Neurosci; 2024 Jun; 15(11):2112-2120. PubMed ID: 38776461
[TBL] [Abstract][Full Text] [Related]
2. Characterization of
Weng CC; Hsiao IT; Yang QF; Yao CH; Tai CY; Wu MF; Yen TC; Jang MK; Lin KJ
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290239
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
Endepols H; Anglada-Huguet M; Mandelkow E; Schmidt Y; Krapf P; Zlatopolskiy BD; Neumaier B; Mandelkow EM; Drzezga A
Mol Neurobiol; 2022 Jun; 59(6):3402-3413. PubMed ID: 35312967
[TBL] [Abstract][Full Text] [Related]
4. Characterization of
Territo PR; Meyer JA; Peters JS; Riley AA; McCarthy BP; Gao M; Wang M; Green MA; Zheng QH; Hutchins GD
J Nucl Med; 2017 Mar; 58(3):458-465. PubMed ID: 27765863
[TBL] [Abstract][Full Text] [Related]
5. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
[TBL] [Abstract][Full Text] [Related]
6. P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice.
Ruan Z; Delpech JC; Venkatesan Kalavai S; Van Enoo AA; Hu J; Ikezu S; Ikezu T
Mol Neurodegener; 2020 Aug; 15(1):47. PubMed ID: 32811520
[TBL] [Abstract][Full Text] [Related]
7. In vivo reactive astrocyte imaging using [
Kong Y; Cao L; Wang J; Zhuang J; Xie F; Zuo C; Huang Q; Shi K; Rominger A; Li M; Wu P; Guan Y; Ni R
J Neurol Sci; 2024 Jun; 462():123079. PubMed ID: 38878650
[TBL] [Abstract][Full Text] [Related]
8. In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy.
Barron AM; Ji B; Fujinaga M; Zhang MR; Suhara T; Sahara N; Aoki I; Tsukada H; Higuchi M
Neurobiol Aging; 2020 Oct; 94():140-148. PubMed ID: 32623260
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Kato T; Hirao K; Shirai N; Sogabe T; Tooyama I
J Neurosci Res; 2018 May; 96(5):841-851. PubMed ID: 29063641
[TBL] [Abstract][Full Text] [Related]
10. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
[TBL] [Abstract][Full Text] [Related]
12. TAPPing into the potential of inducible tau/APP transgenic mice.
Xu G; Ulm BS; Howard J; Fromholt SE; Lu Q; Lee BB; Walker A; Borchelt DR; Lewis J
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12791. PubMed ID: 35067965
[TBL] [Abstract][Full Text] [Related]
13. A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.
Kimura T; Ono M; Seki C; Sampei K; Shimojo M; Kawamura K; Zhang MR; Sahara N; Takado Y; Higuchi M
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4298-4311. PubMed ID: 35798978
[TBL] [Abstract][Full Text] [Related]
14. High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
Tagai K; Ono M; Kubota M; Kitamura S; Takahata K; Seki C; Takado Y; Shinotoh H; Sano Y; Yamamoto Y; Matsuoka K; Takuwa H; Shimojo M; Takahashi M; Kawamura K; Kikuchi T; Okada M; Akiyama H; Suzuki H; Onaya M; Takeda T; Arai K; Arai N; Araki N; Saito Y; Trojanowski JQ; Lee VMY; Mishra SK; Yamaguchi Y; Kimura Y; Ichise M; Tomita Y; Zhang MR; Suhara T; Shigeta M; Sahara N; Higuchi M; Shimada H
Neuron; 2021 Jan; 109(1):42-58.e8. PubMed ID: 33125873
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Reactive Astrocytes, by [
Kong Y; Maschio CA; Shi X; Xie F; Zuo C; Konietzko U; Shi K; Rominger A; Xiao J; Huang Q; Nitsch RM; Guan Y; Ni R
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38502413
[TBL] [Abstract][Full Text] [Related]
16. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.
Han J; Liu H; Liu C; Jin H; Perlmutter JS; Egan TM; Tu Z
Nucl Med Commun; 2017 May; 38(5):372-382. PubMed ID: 28338530
[TBL] [Abstract][Full Text] [Related]
18. Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [
Huang G; Lu X; Qiu Y; Bi L; Ye P; Yang M; Shen Y; Jin H; Han J
Bioorg Med Chem; 2022 Nov; 73():116996. PubMed ID: 36126443
[TBL] [Abstract][Full Text] [Related]
19. (S)-[
Alzghool OM; Rokka J; López-Picón FR; Snellman A; Helin JS; Okamura N; Solin O; Rinne JO; Haaparanta-Solin M
Neuropharmacology; 2021 Sep; 196():108676. PubMed ID: 34216585
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography.
Vagenknecht P; Luzgin A; Ono M; Ji B; Higuchi M; Noain D; Maschio CA; Sobek J; Chen Z; Konietzko U; Gerez JA; Riek R; Razansky D; Klohs J; Nitsch RM; Dean-Ben XL; Ni R
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2137-2152. PubMed ID: 35128565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
